Study guide
5.1 Prescriber Authority, DEA Registration & Out-of-State Prescriptions
Oregon Multistate Pharmacy Jurisprudence Examination MPJE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview & Oregon Legal Framework
1.1 Oregon MPJE Format, Fees, Blueprint & 2027 Changes 1.2 Federal–Oregon Legal Hierarchy, Agencies & the Board of Pharmacy
2 Chapter 2: Pharmacist & Pharmacist-in-Charge Responsibilities
2.1 Pharmacist Responsibilities, Supervision & Prohibited Practices 2.2 Pharmacist-in-Charge: Qualifications, Duties, Inventories & Self-Inspection
3 Chapter 3: Pharmacy Technicians, Interns & Preceptors
3.1 Pharmacy Technicians (COPT & PT): Licensure, Permitted Tasks & Limits 3.2 Pharmacy Interns & Preceptors: Licensure, Scope & Supervision
4 Chapter 4: Licensure, Renewal, Discipline & Impaired Practitioners
4.1 Pharmacist Licensure by Examination, Score Transfer & Reciprocity 4.2 License Renewal, Continuing Pharmacy Education & Lapse Rules 4.3 Grounds for Discipline, Sanctions & Mandatory Reporting Deadlines 4.4 Impaired Practitioners & the Health Professionals' Services Program (HPSP)
5 Chapter 5: Prescriber Authority & Prescription Requirements
5.1 Prescriber Authority, DEA Registration & Out-of-State Prescriptions 5.2 Non-Controlled Prescriptions: Required Elements, Signatures, Expiration & Refills 5.3 Controlled Substance Prescriptions: Schedules II–V, EPCS, Emergency Orders & Oregon's CV Limit 5.4 Drug-Use Limitations & Special Prescriptions: REMS, Death with Dignity, EPT & Standing Orders 5.5 Legitimate Medical Purpose, Corresponding Responsibility & Red Flags
6 Chapter 6: Pharmacist Clinical Services & Prescriptive Authority
6.1 CDTM, Clinical Pharmacy Agreements, MTM & Laboratory Testing 6.2 Pharmacist Prescribing: Statewide Protocols, the Formulary & General Requirements 6.3 Pharmacist Prescribing of Hormonal Contraception (ORS 689.689) 6.4 Tobacco Cessation Protocol: Training, Screening, NRT & Non-NRT Prescribing 6.5 Vaccine Prescribing & Administration: Age Floors, Protocols, Training & ALERT IIS 6.6 Opioid Overdose Reversal & MOUD: Naloxone Prescribing, Standing Orders, Immunity & Buprenorphine
7 Chapter 7: Counseling, Language Access & Confidentiality
7.1 Patient Counseling: Triggers, Who May Offer or Accept a Refusal & Documentation 7.2 Language Access & Accessibility: Dual-Language Labels, Registry Interpreters & Prescription Readers 7.3 Patient Confidentiality: Oregon Rules, HIPAA, Part 2 & PDMP Privacy
8 Chapter 8: The Dispensing Process
8.1 Prospective Drug Utilization Review: Oregon's Eight Categories, Documentation & Who May Perform It 8.2 Oregon PDMP: Reporting Within 72 Hours, Covered Drugs, Access & Confidentiality 8.3 Prescription Transfers: Oregon's Next-Business-Day Duty & Federal Controlled Substance Limits 8.4 Dispensing Exceptions: 72-Hour Emergency Refills, Continuation of Therapy, Insulin & Declared Emergencies 8.5 Partial Fills: Schedule II (72-Hour, 30-Day CARA & 60-Day LTCF/Terminal) and Schedules III–V 8.6 Prescription Labeling: Oregon Elements, Physical Description, Expiration Dating & Med Paks 8.7 Packaging: PPPA Child-Resistant Containers, Waivers, Exemptions & Oregon's New-Container Rule 8.8 Conditions Prohibiting Dispensing, Quarantine, Returned Drugs & Charitable Reuse
9 Chapter 9: Nonprescription & Restricted Products
9.1 Nonprescription Drugs: Outlet Registration, Drug Facts Labeling & OTC Packaging 9.2 Dispensing-Restricted Nonprescription Products: Pseudoephedrine, Exempt Schedule V & Others
10 Chapter 10: Product Selection: Generic & Biologic Substitution
10.1 Product Selection: Generic Substitution (ORS 689.515) & Biologic Interchange (ORS 689.522)
11 Chapter 11: Acquisition, Records, Inventories & Loss Reporting
11.1 Ordering & Acquiring Controlled Substances: DEA Registration, Form 222, CSOS & the 5% Rule 11.2 Distribution Records, DSCSA, Recalls & Oregon Record Retention 11.3 Controlled Substance Inventories: Oregon's 367-Day, 93-Day, 31-Day & 15-Day Rules 11.4 Theft & Loss Reporting, Disposal, Reverse Distribution & Take-Back Receptacles
12 Chapter 12: Pharmacy Operations, Storage, Security & Special Practice Settings
12.1 Pharmacy Operations: Pharmacist Presence, Policies, Equipment, Signage, Hours & Closures 12.2 Drug Storage & Cold Chain: Temperatures, Monitoring Plans, Excursions & Vaccine Units 12.3 Security & Non-Pharmacist Access: Keys, Double Set-Ups, Institutional Night Access & DEA Controls 12.4 Hazardous Drugs: NIOSH 2024 List, USP 800 Controls, Assessment of Risk & Disposal 12.5 Compounding: OAR 855-183 (June 2026), USP 795/797/800, 503A vs. 503B & Beyond-Use Dates 12.6 Delivery of Drugs: Depots, Mail Delivery, Prescription Lockers, Kiosks & Mobile Pharmacies 12.7 Central Fill, Remote Processing, Telework & Remote Dispensing Site Pharmacies
13 Chapter 13: Drug Outlet Registration, Inspection & Institutional Practice
13.1 Drug Outlet Classes, Registration, Changes of Ownership/Location/Name & Non-Resident Pharmacies 13.2 Inspections, Self-Inspection Forms & Discipline of Drug Outlets 13.3 Institutional & Long-Term Care Practice: Drug Rooms, Night Access, E-Kits, ADCs & ED Prepacks
5.1 Prescriber Authority, DEA Registration & Out-of-State Prescriptions
Key Takeaways Explain This Topic AI
Oregon physician associates may prescribe Schedule II–V drugs under a collaboration agreement, and NPs and CNSs with Nursing Board authority prescribe Schedule II–V drugs independently.
The Oregon ND formulary excludes general anesthetics, injectable ketamine, most barbiturates, most systemic oncology drugs and abortifacient mifepristone/misoprostol. Stimulants are not excluded.
Under ORS 689.525, an out-of-state prescription is filled only if authentic and based on a valid patient–practitioner relationship, and generic substitution requires authorization on the prescription.
A DEA number check-digit test adds digits 1, 3 and 5, then adds twice the sum of digits 2, 4 and 6; the last digit of the total must match digit 7.
DEA's fourth temporary telemedicine extension allows controlled substance prescribing without a prior in-person visit through December 31, 2026.
Last updated: October 2026
Why this matters
Before checking whether a prescription is complete, a pharmacist must confirm that the prescriber is authorized to prescribe that drug for that patient. Area 2.1 tests the "scope of authority ... and valid registration of practitioners who are authorized to prescribe, dispense, or administer drugs." In Oregon a valid order needs three things: a state license whose scope covers the drug and condition, a DEA registration for any controlled substance, and a legitimate practitioner–patient relationship.
Oregon prescribers at a glance
- Prescriber Oregon licensing law Prescribing scope a pharmacist must check
- Physician (MD/DO) Oregon Medical Board; ORS 677 Full scope, including Schedules II–V with DEA registration
Physician associate (PA) Oregon Medical Board; ORS 677.510–.511 May prescribe, including Schedules II–V . Must have a collaboration agreement signed by a physician, podiatric physician or employer; with fewer than 2,000 post-graduate hours, the agreement includes a collaboration-hours plan. Oregon renamed physician assistants "physician associates" in 2024
Nurse practitioner (NP) and clinical nurse specialist (CNS) Oregon State Board of Nursing; ORS 678.390 Independent prescriptive authority, including Schedules II–V , when granted by the Nursing Board. No physician supervision is required
Certified registered nurse anesthetist (CRNA) Oregon State Board of Nursing; ORS 678.282 Only with Nursing Board authorization (including Schedules II–V), and only for a patient for whom the CRNA has established a record
- Dentist Oregon Board of Dentistry; ORS 679 Dental scope only
- Podiatric physician Oregon Medical Board; ORS 677.805–.840 Foot and ankle scope
Optometrist Oregon Board of Optometry; ORS 683 Optometric purpose only. A controlled substance prescribed without a legitimate optometric purpose is a disciplinary ground
Naturopathic physician (ND) Oregon Board of Naturopathic Medicine; ORS 685 Only drugs on the naturopathic formulary set by the Council on Naturopathic Physicians Formulary (ORS 685.145) and adopted by rule
Veterinarian ORS 686 Animals only. The prescription names the animal, the owner and the species
Pharmacist ORS 689.645, .689, .696, .698, .704 Only by formulary, statewide protocol, CDTM or a specific statute (Chapter 6)
Naturopathic physicians: a frequent trap
Oregon NDs prescribe from a formulary based on the American Hospital Formulary Service (AHFS) pharmacologic-therapeutic classification (OAR 850-060-0226). The formulary has specific exclusions (OAR 850-060-0223):
General anesthetics and injectable ketamine .
Barbiturates, except phenobarbital, butalbital and primidone.
Systemic oncology agents, except a short list of oral and topical agents such as methotrexate, tamoxifen, anastrozole and letrozole.
Mifepristone and misoprostol used as an abortifacient.
Anything not in the AHFS classification or approved by the Board.
Controlled substances are not excluded as a class. An Oregon ND with a DEA registration may prescribe a scheduled drug in an included class, such as a Schedule II stimulant for ADHD. ORS 689.635 lets a pharmacist dispense an ND formulary prescription and says that doing so is not evidence of negligence if done within reasonable and prudent practice.
DEA registration and the "valid registration" check
Federal law (21 CFR 1306.03) allows only an individual practitioner who is authorized by the state and registered with DEA (or exempt, like certain federal or institutional practitioners) to issue a controlled substance prescription. On a controlled substance prescription, the pharmacist should confirm:
A DEA number in the expected format: two letters and seven digits. The first letter shows the registrant type (for example A, B, F or G for practitioners, M for mid-level practitioners). The second letter is usually the first letter of the prescriber's last name.
The check digit. Add the 1st, 3rd and 5th digits. Add the 2nd, 4th and 6th digits and double that sum. Add the two results; the last digit of the total must equal the 7th digit.
That the prescribed schedule is within both the DEA registration and the state authority. A DEA registration never expands a state scope of practice.
Out-of-state prescribers (ORS 689.525)
An Oregon pharmacist may fill a prescription from a practitioner licensed in another U.S. state or territory only after deciding, in professional judgment, that it was issued under a valid patient–practitioner relationship and that it is authentic . If the prescriber is unknown to the pharmacist, the pharmacist must obtain proof of validity to a reasonable certainty.
Important
ORS 689.525(3) provides that the generic substitution authority of ORS 689.515 does not apply to an out-of-state prescription unless the prescription authorizes it . This is an Oregon-specific rule that is easy to miss.
Telemedicine and controlled substances
The federal Ryan Haight Online Pharmacy Consumer Protection Act generally requires at least one in-person medical evaluation before a controlled substance is prescribed by means of the internet. A practice-of-telemedicine exception applies. DEA and HHS have repeatedly extended COVID-era telemedicine flexibilities . The fourth temporary extension runs through December 31, 2026 . Until then, DEA-registered practitioners may prescribe Schedule II–V drugs after an audio-video telemedicine encounter without a prior in-person visit, and may prescribe Schedule III–V opioid use disorder medications after an audio-only encounter. Pharmacists still exercise corresponding responsibility, covered in section 5.5. An order based only on an online questionnaire, with no real clinical evaluation, does not establish a legitimate practitioner–patient relationship.
Exam scenario
An Oregon pharmacy receives three prescriptions:
Methylphenidate from an Oregon ND who holds a DEA registration. Methylphenidate is in an included AHFS class and is not on the ND exclusion list, so the pharmacist processes it after the usual controlled substance checks.
Lisinopril from a dentist for a patient's hypertension. This is outside dental scope, so the pharmacist contacts the dentist and declines to fill it as written.
Atorvastatin written by brand name by a California physician , with no substitution instruction. ORS 689.525(3) bars generic substitution unless authorized, so the pharmacist dispenses the brand or obtains the prescriber's authorization to substitute.